BridgeMD
New treatment option for Cerebral Palsy
Official title Feasibility of an In-home Standing and Walking Intervention for Infants With and at High Risk of Cerebral Palsy
ClinicalTrials.gov ID: NCT05781438
What this study is testing
- What it's testing
- The purpose of this study is to evaluate the feasibility and begin to evaluate the effect of an intensive in-home standing and walking intervention for infants with or at high risk of cerebral palsy.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 5 to 2
You may be able to join if
- Infants with or at high risk of cerebral palsy (CP) who either:
- have been diagnosed with CP by a medical professional, or
- are at high risk of CP defined as having both:
- clinical brain imaging indicating CP, such as (i) white matter injury (cystic periventricular leukomalacia or periventricular hemorrhagic...
- a score less than 63 or more than 5 asymmetries on the Hammersmith Infant Neurological Examination (HINE).
You likely can't join if
- prenatal substance abuse,
- congenital malformations,
- drug-resistant epilepsy,
- visual impairment that hinders the infant from seeing toys,
- hearing impairment that hinders the infant from responding to sound,
- living in a location inaccessible by study personnel for in-home data collections,
See the full eligibility criteria
- Infants with or at high risk of cerebral palsy (CP) who either:
- have been diagnosed with CP by a medical professional, or
- are at high risk of CP defined as having both:
- clinical brain imaging indicating CP, such as (i) white matter injury (cystic periventricular leukomalacia or periventricular hemorrhagic infarctions), (ii) hypoxic-ischemic encephalopathy, or (iii) neonatal stroke, and
- a score less than 63 or more than 5 asymmetries on the Hammersmith Infant Neurological Examination (HINE).
- prenatal substance abuse,
- congenital malformations,
- drug-resistant epilepsy,
- visual impairment that hinders the infant from seeing toys,
- hearing impairment that hinders the infant from responding to sound,
- living in a location inaccessible by study personnel for in-home data collections,
- participant over 50 lbs in weight.
The study team makes the final eligibility decision.
Where it's taking place
- Los Angeles, California, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 5 months to 2 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Los Angeles, California, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.